HPCA-Associated Dystonia (DYT2): A Patient Guide
At a Glance
HPCA-associated dystonia, formerly called DYT2, is a rare inherited movement disorder caused by two non-working HPCA gene copies. Genetic testing usually confirms it, while care focuses on personalized symptom support and rapid hospital treatment for a sudden, severe worsening.
Receiving a rare diagnosis can feel overwhelming, but understanding the condition is the first step in taking control of your care. HPCA-associated dystonia, formerly known as DYT2, is an exceptionally rare genetic movement disorder that primarily affects how the brain coordinates muscle activity. It is an autosomal recessive condition, meaning it occurs when a person inherits two copies of a non-working HPCA gene—one from each biological parent. This gene is responsible for creating hippocalcin, a protein that helps brain cells in the striatum (the movement control center) manage calcium signals. Current biological models propose that without functioning hippocalcin, these brain cells may become overactive, leading to the involuntary muscle twisting and sustained postures that characterize dystonia [1][2].
The condition typically begins in childhood or adolescence, often starting as focal dystonia in a single limb or the neck. Over time, these symptoms frequently progress to generalized dystonia, where the movements affect most of the body. While the primary issue is motor control, researchers have noted that some individuals also experience occasional non-motor features, such as developmental delays, speech difficulties, or cognitive challenges. Because the physical structure of the brain is usually unaffected, a standard brain MRI will typically appear normal. While an MRI is helpful for ruling out other issues, specialized genetic testing is usually needed to establish a molecular diagnosis [2][3].
Because this condition is so rare, the most critical step in early management is ruling out “look-alike” conditions that have specific, life-changing treatments. Disorders like Wilson disease or Dopa-Responsive Dystonia (DRD) can mimic the symptoms of HPCA variants but require entirely different medical interventions. Once these mimics are ruled out, care transitions to a highly individualized, multidisciplinary approach. There is currently no single “cure” for HPCA-associated dystonia; instead, a team of specialists works together to manage symptoms, prevent complications like joint stiffness, and support quality of life [4][5].
Living with this diagnosis also requires awareness of a rare but serious emergency called status dystonicus, or a “dystonic storm.” This is an escalation of muscle spasms that can evolve over hours or days and may be life-threatening if not treated in a hospital. While the rarity of the condition means local doctors may have never seen it, having a specialized care team—including movement disorder specialists, your primary care physician, and therapists—ensures that unique needs are monitored. By focusing on nutrition, communication, and tailored interventions, families and patients can navigate the complexities of this rare journey with a clear and proactive plan [6][7].
In this guide
6 chapters
Understanding HPCA-Associated Dystonia (DYT2)
Learn how HPCA-associated dystonia relates to DYT2, including childhood symptoms, genetic inheritance, progression, MRI findings, and questions for your care team.
Symptoms and Emergency Warning Signs
Learn the symptoms of DYT2 (HPCA-associated) dystonia, how symptoms may spread, and which warning signs of status dystonicus require immediate emergency care.
Diagnosis and Ruling Out Look-Alikes
Learn how DYT2 (HPCA) dystonia is confirmed with genetic testing and how doctors rule out treatable mimics like DRD, Wilson disease, and manganese disorders.
Standard of Care and Interventions
Learn how HPCA-associated DYT2 dystonia is treated with oral medicines, botulinum toxin injections, and GPi deep brain stimulation, including risks of DBS.
Daily Management and Quality of Life
Learn how to manage DYT2 dystonia day to day, including swallowing, communication, pain, contractures, rehabilitation, nutrition, and quality-of-life support.
Building Your Care Team
Learn how to build an HPCA-associated dystonia care team and prepare for specialist visits with home videos, genetic reports, MRI files, and medication records.
Common questions in this guide
What is HPCA-associated dystonia, and is it the same as DYT2?
How is HPCA-associated dystonia diagnosed?
Which treatable conditions should be ruled out first?
What care is available if there is no cure?
What should I do if dystonia suddenly becomes much worse?
What does autosomal recessive inheritance mean for my family?
Get notified when new evidence is published on Primary dystonia, DYT2 type.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Mutations in HPCA cause autosomal-recessive primary isolated dystonia.
Charlesworth G, Angelova PR, Bartolomé-Robledo F, et al.
American journal of human genetics 2015; (96(4)):657-65.
PMID: 25799108 - 2
Childhood-Onset Choreo-Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature Review.
Magrinelli F, Bhatia KP, Beiraghi Toosi M, et al.
Movement disorders clinical practice 2023; (10(1)):101-108 doi:10.1002/mdc3.13529.
PMID: 36698997 - 3
Specific Cognitive Changes due to Hippocalcin Alterations? A Novel Familial Homozygous Hippocalcin Variant Associated with Inherited Dystonia and Altered Cognition.
Siegert S, Schmidt WM, Pletschko T, et al.
Neuropediatrics 2021; (52(5)):377-382 doi:10.1055/s-0040-1722686.
PMID: 33511595 - 4
Clinical Management of Dystonia in Childhood.
Luc QN, Querubin J
Paediatric drugs 2017; (19(5)):447-461 doi:10.1007/s40272-017-0243-3.
PMID: 28620849 - 5
The genetic landscape of childhood-onset dystonia in a nationwide Turkish cohort: Clinical spectrum, molecular diagnostics, and therapeutic implications.
Yilmaz S, Serdaroglu E, Simsek E, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (62()):51-60 doi:10.1016/j.ejpn.2026.06.003.
PMID: 42308683 - 6
Status Dystonicus: An Updated Review on Diagnosis, Pathophysiology, and Management.
Desai VN, Garg A, Bhattacharya A, et al.
Annals of Indian Academy of Neurology 2026; (29(4)):501-509 doi:10.4103/aian.aian_1122_25.
PMID: 42574201 - 7
Emerging Subspecialties: Pediatric Movement Disorders Neurology.
Kahlon S, Barton CR, Abu Libdeh A, et al.
Neurology 2024; (102(2)):e208050 doi:10.1212/WNL.0000000000208050.
PMID: 38165345
This page is for informational purposes only and does not constitute medical advice. A movement-disorder or genetics specialist should interpret your test results and advise you about symptoms, care, and emergencies.